Chemistry Wealth Management
TCAF icon

Chemistry Wealth Management’s T. Rowe Price Capital Appreciation Equity ETF TCAF Stock Holding History

Chemistry Wealth Management’s Portfolio TCAF Stock Details TCAF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.5M Buy
201,000
+6,752
+3% +$285K 1.33% 16
2026
Q2 		$7.98M Buy
194,248
+10,049
+5% +$397K 1.28% 15
2026
Q1 		$6.56M Buy
184,199
+5,964
+3% +$223K 1.15% 17
2025
Q4 		$6.81M Buy
178,235
+14,711
+9% +$564K 1.27% 15
2025
Q3 		$6.16M Buy
163,524
+8,435
+5% +$308K 1.19% 16
2025
Q2 		$5.47M Buy
155,089
+12,562
+9% +$412K 1.17% 16
2025
Q1 		$4.6M Buy
142,527
+14,916
+12% +$500K 1.07% 18
2024
Q4 		$4.25M Buy
127,611
+17,251
+16% +$582K 1% 19
2024
Q3 		$3.67M Buy
110,360
+16,382
+17% +$525K 0.87% 22
2024
Q2 		$2.95M Buy
93,978
+35,498
+61% +$1.08M 0.76% 25
2024
Q1 		$1.77M Buy
58,480
+36,348
+164% +$1.05M 0.48% 39
2023
Q4 		$612K Buy
+22,132
New +$573K 0.18% 83

Other funds holding TCAF

LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $483B AUM 41.26% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return
Consolidated Planning Corp
Consolidated Planning Corp Atlanta, Georgia $735M AUM 14.62% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Mesirow Financial Investment Management
Mesirow Financial Investment Management Chicago, Illinois $6.47B AUM 15.41% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Level Four Advisory Services
Level Four Advisory Services Dallas, Texas $3.46B AUM 29.55% 1-Year Est. Return

Chemistry Wealth Management's TCAF Position: Q3 2026 in Review

Chemistry Wealth Management increased its T. Rowe Price Capital Appreciation Equity ETF (TCAF) stake by 3.5% in Q3 2026, buying an estimated $285K and bringing the position to 201,000 shares worth $8.5M. The position accounts for 1.33% of the portfolio, ranked #16.

Chemistry Wealth Management first reported a position in TCAF in Q4 2023 and has held it in 12 quarters since. 208 funds tracked by Wall St. Rank hold TCAF as of Q3 2026.

  • Chemistry Wealth Management held 201,000 shares of T. Rowe Price Capital Appreciation Equity ETF worth $8.5M as of Q3 2026.
  • Chemistry Wealth Management bought 6,752 T. Rowe Price Capital Appreciation Equity ETF shares in Q3 2026, an estimated $285K.
  • T. Rowe Price Capital Appreciation Equity ETF made up 1.33% of Chemistry Wealth Management's portfolio in Q3 2026, its #16 holding.
  • Chemistry Wealth Management first reported a position in T. Rowe Price Capital Appreciation Equity ETF in Q4 2023 and has held it in 12 quarters since.
  • 208 funds tracked by Wall St. Rank held T. Rowe Price Capital Appreciation Equity ETF as of Q3 2026.

Based on Chemistry Wealth Management's 13F filing for Q3 2026, filed 16 Oct 2026.